🧬 ICD-10 CM R29.810 — Facial Weakness

Billable Code Confirmed

ICD-10 CM R29.810 is a valid and billable ICD-10-CM diagnosis code located in Chapter 18 under symptoms, signs and abnormal clinical and laboratory findings. The code sits within the R29.81 subcategory for facial droop and captures documented facial weakness or facial drooping when a more specific definitive diagnosis code is not yet established or is not appropriate. It is a 7-character code that meets specificity requirements for claim submission and is valid for FY2026 encounters.^1,2

Non-Billable Parent Codes

R29.81 is a non-billable parent subcategory for facial droop and facial weakness. It does not carry sufficient specificity on its own for claim submission and must be reported at the child-code level such as R29.810 or R29.818.^1,2

R29.8 is a broader non-billable parent covering other symptoms and signs involving the nervous and musculoskeletal systems. It has no clinical specificity as a standalone code and should not be used when a child code accurately reflects the documented finding.^1,2

R29 is the non-billable category header for other symptoms and signs involving the nervous and musculoskeletal systems. It does not specify any particular symptom and should never be submitted as a final reportable diagnosis.^1,2

Clinical Context

ICD-10 CM R29.810 is most appropriate when a clinician documents facial weakness or facial droop without a confirmed underlying etiology such as Bell’s palsy or cerebrovascular disease at the time of the encounter. In emergency and acute settings it frequently appears when stroke is being ruled out and the presenting symptom is facial drooping, because ICD-10-CM guidelines prohibit coding “rule out” diagnoses and require coding the presenting sign instead. When the underlying cause is confirmed, the definitive diagnosis code should replace or supplement R29.810 per Chapter 18 guidelines.^3,4

Code Classification

ICD-10 CM R29.810 is a diagnosis code and specifically a symptom/sign code from ICD-10-CM Chapter 18. It is not a procedure code, not an ICD-10-PCS code, and not an HCC diagnosis code in the reviewed sources.^1,2


🔍 Code Description

ICD-10 CM R29.810 describes documented facial weakness or facial droop, meaning a clinically observed or patient-reported reduction in the strength or movement of the facial muscles that has not been attributed to a definitive confirmed diagnosis at the time of coding. The code includes the synonym “facial droop,” making it applicable when either term appears in provider documentation. As a Chapter 18 symptom code, it follows the coding principle that it should be used in the absence of a confirmed diagnosis, and it should not be reported alongside a confirmed related definitive code when the symptom is integral to that condition. The code has been stable in the ICD-10-CM classification for multiple fiscal years, and it carries a specific chronic condition indicator noting it is not a chronic condition, which reinforces its role as an acute presenting symptom.^1,2,4

The clinical range of conditions that may initially present as facial weakness is broad and includes stroke, Bell’s palsy, Ramsay Hunt syndrome, myasthenia gravis, multiple sclerosis, neoplasm, and trauma, among others. The critical distinction in inpatient coding is that once the etiology is confirmed, the specific condition code takes priority over R29.810, and for cerebrovascular disease specifically, the I69 family with final characters -92 directly replaces this symptom code as an Excludes1 directive. When used during pre-diagnosis workup or when no confirmed etiology is documented, R29.810 accurately captures the clinical encounter without overstating the confirmed diagnosis. Coders should flag cases where facial weakness is documented as a residual from any prior cerebrovascular event, because those cases belong to the I69.092, I69.192, I69.292, I69.892, or I69.992 codes rather than to R29.810.^3,4,5


🌳 Code Tree / Hierarchy

R29 Other symptoms and signs involving the nervous and musculoskeletal systems ❌ Non-billable
│
├── R29.0 Tetany ✅ Billable
├── R29.1 Meningismus ✅ Billable
├── R29.2 Abnormal reflex ✅ Billable
├── R29.3 Abnormal posture ✅ Billable
├── R29.4 Clicking hip ✅ Billable
├── R29.5 Transient paralysis ✅ Billable
│
├── R29.6 Repeated falls ✅ Billable
│
├── R29.7 National Institutes of Health stroke scale (NIHSS) score ❌ Non-billable
│ └── (Child codes R29.700–R29.744 for specific NIHSS scores) ✅ Billable
│
├── R29.81 Facial droop ❌ Non-billable
│ │
│ ├── R29.810 Facial weakness ◀ THIS CODE ✅ Billable
│ └── R29.818 Other signs and symptoms involving the nervous system ✅ Billable
│
└── R29.89 Other specified symptoms and signs involving the musculoskeletal system ✅ Billable

Symptom Coding at Its Finest

ICD-10 CM R29.810 is a classic “rule-out stroke” symptom code. ICD-10-CM guidelines prohibit coding unconfirmed diagnoses, so when the ED or inpatient workup has not yet confirmed whether facial droop is from stroke, Bell’s palsy, or another cause, this code is the correct choice rather than reaching for a speculative etiologic code.^3,4

Tip

The Excludes1 structure for R29.810 is sharp and significant — both G51.0 for Bell’s palsy and all I69 codes with final characters -92 are hard Excludes1 exclusions, meaning you cannot report R29.810 simultaneously with those codes for the same condition. Make sure the underlying etiology is truly undetermined before assigning R29.810 on a final coded record.^1,5


âś… Includes

  • Facial droop documented as a presenting sign or symptom without a confirmed etiologic diagnosis at the time of the encounter. This is the most common appropriate use of R29.810 in emergency and acute settings.^1,2
  • Facial muscle weakness, whether unilateral or bilateral, when not attributable to a confirmed condition that has its own ICD-10-CM code. The code does not carry a laterality character, so it applies regardless of which side is affected.^2,3
  • Facial weakness as the presenting sign in an unresolved neurologic workup where the provider documents the observable finding and evaluation is ongoing. Chapter 18 guidelines support symptom-code reporting in these circumstances.
  • Facial drooping documented in a patient without a prior cerebrovascular event on record and without confirmed Bell’s palsy or other named facial nerve condition. The absence of a confirmable etiology is the key condition for appropriate use.^3,5
  • Documentation of facial droop as an isolated finding, such as a medication side effect observation or an isolated assessment note without etiologic elaboration, when no more specific reportable diagnosis applies.

❌ Excludes

Excludes 1

  • G51.0 — Bell’s palsy. This is a hard exclusion because Bell’s palsy is the definitive idiopathic peripheral facial nerve palsy diagnosis and fully explains the facial weakness presentation. R29.810 should not be reported alongside G51.0 for the same facial weakness episode.^1,5
  • I69**.-92** — Facial weakness following cerebrovascular disease, covering I69.092, I69.192, I69.292, I69.892, and I69.992. Each of these I69 codes with final characters -92 captures facial weakness as a sequela of a specific cerebrovascular disease type and replaces R29.810 entirely when the cerebrovascular etiology is established.^1,5

Danger

The most common Excludes1 error with R29.810 is continuing to report this symptom code after a cerebrovascular sequela has been confirmed and coded. Once the provider documents that the facial weakness is attributable to a prior stroke or other cerebrovascular disease, the appropriate I69.-92 code must replace R29.810, and the two cannot coexist on the same claim for the same condition.^1,5

Excludes 2

  • No specific Excludes2 note was confirmed in the reviewed sources directly under R29.810. General ICD-10-CM convention still applies: conditions that are not integral to the documented facial weakness and have no Excludes1 conflict may be coded separately when clinically supported.

đź“‹ Clinical Overview

Facial Weakness vs. Confirmed Etiologic Diagnoses

The core clinical coding challenge with R29.810 is distinguishing it from conditions that have their own specific ICD-10-CM codes. Facial weakness as a presenting sign belongs to Chapter 18, but once an etiology is established, the diagnosis chapter for that etiology takes over. The following table captures the most clinically important distinctions a coder must navigate.^1,3,5

Feature[[R29.810]]G51.0I69.092 / I69.192 / I69.992
Etiology statusNo confirmed etiology at time of coding; symptom is the reportable finding.^1,4Confirmed idiopathic peripheral facial nerve palsy; definitive diagnosis established.^1,5Confirmed facial weakness as sequela of a specific prior cerebrovascular event.^1,5
Excludes1 relationshipNone applicable to itself; excluded by both G51.0 and I69.-92 when those conditions are confirmed.^1Hard Excludes1 against R29.810; Bell’s palsy replaces the symptom code when confirmed.^1Hard Excludes1 against R29.810; the appropriate I69.-92 code replaces R29.810 when cerebrovascular etiology is confirmed.^1,5
Inpatient principal Dx useCan be principal Dx only if no confirmed diagnosis is established by discharge.^2,4Can be principal Dx when confirmed as the reason for admission and care.^1Typically secondary unless the entire encounter is focused on management of the cerebrovascular sequela.^4

Important

A strong CDI trigger for R29.810 cases is any history of prior stroke, TIA, or cerebrovascular disease in the chart. If facial weakness or droop is documented alongside that history, the provider should be queried to determine whether the facial weakness is a residual sequela of the past event or a new unrelated presentation, because the answer directly changes the code family used.^3,5

Manifestations & Symptom Burden

  • Unilateral facial drooping, which may be reported by the patient or observed by clinical staff during neurologic assessment. This is one of the classic FAST (Face, Arms, Speech, Time) stroke-recognition signs.^3,4
  • Difficulty closing one or both eyelids fully due to orbicularis oculi weakness. This functional limitation may also overlap with ophthalmologic assessment needs.^2,3
  • Speech impairment or drooling secondary to perioral muscle weakness. When these findings coexist with R29.810, coders should evaluate whether separate symptom codes or confirmed diagnosis codes better represent each documented finding.^2,4
  • Asymmetrical facial appearance during attempted muscle movement, frequently noted in the neurologic exam. The coder relies on the provider’s language to determine whether the finding is a discrete deficit or part of a broader confirmed diagnosis.^2,3
  • Difficulty with facial expression, chewing, or fine facial movement. These functional observations should be linked clearly to the coded finding in documentation for medical necessity support.

Tip

ICD-10 CM R29.810 should not be reported separately when the facial weakness is documented as integral to a confirmed condition already being coded. The ICD-10-CM guideline for Chapter 18 is explicit that signs and symptoms that are routinely associated with a definitive diagnosis should not be reported as additional codes unless the classification instructs otherwise. If the confirmed condition is coded, do not pile on with the symptom code just to capture documentation of the symptom.^4,6


đź’° HCC Risk Adjustment

ItemDetail
HCC statusNot HCC-mapped per sources reviewed for R29.810.^1,2
RAF impactNo independent HCC-based RAF effect confirmed.^1,2
Capture ruleReport when facial weakness is documented as the clinically addressed finding without a confirmed underlying diagnosis at the time of coding.^2,4
Documentation needProvider should describe the observable finding, note absence of confirmed etiology if relevant, and link to any workup ordered.^2,4
Coding cautionReplace R29.810 with a specific etiology code — such as G51.0 or an I69.-92 code — as soon as the underlying cause is confirmed in the record.^1,5

ICD-10 CM R29.810 sits in Chapter 18 as a symptom and sign code and does not carry HCC risk-adjustable value in the reviewed sources. For risk adjustment accuracy, the emphasis should always be on capturing the underlying confirmed diagnosis when one exists, because that code will carry the clinical and financial weight of the encounter rather than the symptom code. In ambulatory and risk-adjustment-focused settings, relying on a symptom code when a definitive diagnosis has been established represents both a coding error and a missed recapture opportunity. In the inpatient professional fee environment, coders should ensure that any confirmed diagnosis supersedes R29.810 on the final coded record and that symptom-only records are flagged for physician clarification before final submission.^1,2,4


🏥 MS-DRG Assignment

ElementDetail
DRG assignment basisMS-DRGs are assigned from the entire inpatient claim, not from R29.810 alone.^7
Principal diagnosis rulePer ICD-10-CM, R29.810 should not be principal Dx when a confirmed related diagnosis is documented.^2,4
Sequencing riskIncorrectly keeping R29.810 as principal Dx when an etiology was confirmed by discharge can produce a lower-weighted DRG and audit risk.^4,7
MDC contextA symptom-only neurologic presentation without confirmed etiology may group to a lower-acuity medical DRG compared to confirmed stroke or Bell’s palsy.^7
CC/MCC impactR29.810 is a symptom code; no fixed CC/MCC designation was confirmed in the reviewed sources for this code in isolation.^7

In the inpatient profee coding world — which is exactly your lane — the practical concern with R29.810 is ensuring it doesn’t stay on the claim as a principal diagnosis if the attending confirmed a stroke, Bell’s palsy, or cerebrovascular sequela before the patient was discharged. CMS IPPS coding guidelines require the principal diagnosis to be the condition established after study to be chiefly responsible for the inpatient admission, and a symptom code should yield that position to the confirmed diagnosis. A full review of the discharge summary, attending attestation, and any specialty notes is essential before finalizing the coded record when R29.810 is in a potential principal position.^4,7


Facial/Nerve Weakness and Palsy Codes

  • G51.0 — Bell’s palsy; definitive Excludes1 condition and the most common cause of unilateral facial weakness in the general population.^1,5
  • G51.8 — Other disorders of facial nerve, for other named facial nerve pathology.
  • G70.00 — Myasthenia gravis without (acute) exacerbation; can present with facial muscle weakness.

Cerebrovascular Sequela Facial Weakness Codes

  • I69.092 — Facial weakness following nontraumatic subarachnoid hemorrhage.
  • I69.192 — Facial weakness following nontraumatic intracerebral hemorrhage.
  • I69.292 — Facial weakness following other nontraumatic intracranial hemorrhage.
  • I69.892 — Facial weakness following other cerebrovascular disease.
  • I69.992 — Facial weakness following unspecified cerebrovascular disease.

🛠️ Commonly Associated CPT Codes

  • 97110 — Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion, and flexibility. This is frequently billed in physical or occupational therapy focused on facial muscle strengthening or neuromuscular retraining.^2,8
  • 97112 — Neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception. This may be relevant when facial weakness is associated with broader neuromuscular deficits being addressed in therapy.^2,8
  • 92507 — Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual. Applicable when facial weakness is contributing to a speech or communication impairment that is being actively treated.^2,8
  • 95933 — Orbicularis oculi response (blink reflex). This electrodiagnostic study may be ordered to evaluate facial nerve function in workup of facial weakness.
  • 95905 — Motor and/or sensory nerve conduction, using preset electrode array; for nerve conduction studies used in the evaluation of facial nerve pathology contributing to weakness.

NCCI Bundling Considerations

NCCI bundling details for the specific CPT codes associated with R29.810 were not directly confirmed in the reviewed sources for this diagnostic context, and coding teams should verify current NCCI edits and payer-specific policies before final claim submission. In therapy settings, timed therapy codes such as 97110 and 97112 are subject to the 8-minute rule and unit-counting rules that govern their billing. Diagnostic electrodiagnostic codes should be billed according to the actual study performed, with supporting documentation confirming the indication. Facial weakness as a documented diagnosis supports medical necessity for these services but does not guarantee reimbursement without meeting payer-level coverage criteria.^6,7


🔬 ICD-10-PCS Crosswalk

  • F01Z8ZZ — Speech and language assessment using augmentative/alternative communication device. In inpatient settings, speech-language assessment services may be captured in PCS when performed and documented to standard, particularly when facial weakness affects communication.
  • F07Z0ZZ — Motor treatment using orthotic device. Physical or occupational therapy addressing facial neuromuscular deficits may generate a PCS rehabilitation code depending on the inpatient setting and documented service.
  • 4A00X4Z — Measurement of central nervous system electrical activity, external approach. Nerve conduction or electromyographic studies ordered during inpatient workup of facial weakness may generate a PCS measurement and monitoring code, subject to facility policy and documentation.

đź’Š Coding Scenarios and Examples

Scenario 1

A patient presents to the emergency department with sudden onset right-sided facial drooping and no prior history of stroke or neurologic condition. The emergency physician documents “facial droop, right side — rule out stroke.” CT brain is performed and is negative for acute infarct. MRI is ordered but results are pending at the time of coding. No confirmed diagnosis is documented at discharge from the ED encounter. ICD-10-CM guidelines prohibit coding “rule out” diagnoses, so the presenting sign is coded.
Correct coding list: R29.810
Sequencing explanation: R29.810 is appropriate as the principal diagnosis because no confirmed definitive etiology was established and the provider documented the presenting finding rather than a confirmed diagnosis.^3,4
CDI note: If MRI results return and confirm stroke or Bell’s palsy before the encounter is coded, the confirmed diagnosis should replace or take the principal position over R29.810.

Scenario 2

A patient with a known history of prior cerebral infarction presents for neurology follow-up and the physician documents persistent left-sided facial weakness with drooping that the neurologist attributes to the prior stroke. The weakness has been present since the patient’s acute infarct and has not resolved. No new acute stroke is occurring. This is a sequela of the prior cerebrovascular event.
Correct coding list: I69.992 or the appropriate I69.-92 code matched to the documented stroke type from the prior event
Sequencing explanation: The I69 sequela code with final characters -92 replaces R29.810 per the Excludes1 directive whenever the facial weakness is attributable to prior cerebrovascular disease. R29.810 must not be used in this scenario.^1,5
CDI note: If the prior stroke type is documented in the chart, select the specific I69.-92 code matching that event rather than defaulting to I69.992 (unspecified).

Scenario 3

A patient is admitted to an inpatient neurology unit for workup of new-onset facial droop and the workup over the course of the stay confirms Bell’s palsy based on clinical exam, patient history, and imaging that rules out a central cause. The attending documents “Bell’s palsy” as the confirmed diagnosis at discharge. By the time of final coding, the definitive diagnosis is established.
Correct coding list: G51.0
Sequencing explanation: G51.0 replaces R29.810 entirely because Bell’s palsy is now the confirmed diagnosis. The Excludes1 note prevents both codes from being reported for the same condition, and the confirmed definitive diagnosis code takes precedence over the symptom code.^1,5
CDI note: Ensure the attending physician’s discharge documentation reflects “Bell’s palsy” clearly, because the coding hinges on the confirmed definitive diagnosis statement rather than the presenting symptom note.^1,4


⚠️ Coding Pitfalls and Tips

  • Do not keep R29.810 as principal diagnosis if the etiology was confirmed before discharge. Chapter 18 guidelines explicitly state that symptom codes should not be reported when a confirmed related diagnosis is established. If an inpatient workup confirmed stroke or Bell’s palsy before the patient left, the confirmed diagnosis must take the principal position.^2,4
  • Do not report R29.810 alongside G51.0 for the same clinical presentation. The Excludes1 note is a hard stop — these two codes cannot be reported together for the same episode of facial weakness. Bell’s palsy is the definitive code and fully replaces the symptom code when confirmed.^1,5
  • Do not report R29.810 alongside any I69 code with final characters -92 for the same facial weakness. The Excludes1 rule equally prohibits dual reporting of the symptom code and the cerebrovascular sequela code for the same condition. Always verify whether the patient has a relevant cerebrovascular history before finalizing R29.810 on the record.^1,5
  • Do not add R29.810 as an extra code when facial weakness is integral to a confirmed condition already coded. Chapter 18 guidelines prohibit reporting signs and symptoms that are routinely associated with a disease process when the definitive condition is being coded. Adding R29.810 on top of a confirmed stroke or Bell’s palsy code is a coding error.^4,6
  • Always check the chart for cerebrovascular history before finalizing R29.810. The I69 family exclusion is only triggered when the provider documents or confirms that the facial weakness is attributable to prior cerebrovascular disease. A remote CVA in the past medical history is not automatically a link; the provider must associate the current deficit with the prior event.^1,5
  • Verify that “facial weakness” in the documentation is not being used loosely to describe a confirmed neurologic condition. Providers sometimes document the symptom without naming the diagnosis, especially in nursing or therapy notes. Review the attending’s discharge diagnosis, attestation, and any specialist notes before selecting R29.810 over a definitive code.^2,4

📚 Sources

1. AAPC. *ICD-10 Code for Facial weakness — R29.810.* Codify by AAPC. Accessed 2026.^1 2. icdlist.com. *2025 ICD-10-CM Diagnosis Code R29.810 — Facial weakness.* Accessed 2026.^2 3. iRCM Inc. *Stroke-Like Symptoms ICD-10 & TIA Code Explained.* 2025.^3 4. Net Health. *Breaking Down Weakness ICD-10 Codes.* February 2025.^4 5. GenHealth.ai. *R29.810 ICD-10-CM — Facial weakness.* Accessed 2026.^5 6. ACDIS. *Q&A: Clarifying inclusion and exclusion notes.* 2020.^6 7. CMS. *MS-DRG Classifications and Software.* Updated 2026.^7 8. MD Clarity. *ICD Diagnosis Code R29.810: What It Is & When to Use.* 2024.^8